amphetamine has been researched along with Infarction, Middle Cerebral Artery in 4 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to examine the effects of d-amphetamine (amph) upon recovery after embolic stroke in rats." | 7.77 | Acute but not delayed amphetamine treatment improves behavioral outcome in a rat embolic stroke model. ( Johansen, FF; Kristiansen, U; Overgaard, K; Rasmussen, RS, 2011) |
| "The objective of this study was to examine the effects of d-amphetamine (amph) upon recovery after embolic stroke in rats." | 3.77 | Acute but not delayed amphetamine treatment improves behavioral outcome in a rat embolic stroke model. ( Johansen, FF; Kristiansen, U; Overgaard, K; Rasmussen, RS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linden, J | 1 |
| Van de Beeck, L | 1 |
| Plumier, JC | 1 |
| Ferrara, A | 1 |
| Rasmussen, RS | 1 |
| Overgaard, K | 1 |
| Kristiansen, U | 1 |
| Johansen, FF | 1 |
| Loewenhardt, B | 1 |
| Bernhard, M | 1 |
| Pierskalla, A | 1 |
| Neumann-Haefelin, T | 1 |
| Hofmann, E | 1 |
| Veizovic, T | 1 |
| Beech, JS | 1 |
| Stroemer, RP | 1 |
| Watson, WP | 1 |
| Hodges, H | 1 |
4 other studies available for amphetamine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Procedural learning as a measure of functional impairment in a mouse model of ischemic stroke.
Topics: Amphetamine; Animals; Body Weight; Cognition Disorders; Disease Models, Animal; Functional Lateralit | 2016 |
Acute but not delayed amphetamine treatment improves behavioral outcome in a rat embolic stroke model.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration | 2011 |
Neurointerventional treatment of amphetamine-induced acute occlusion of the middle cerebral artery by intracranial balloon angioplasty.
Topics: Adult; Amphetamine; Angioplasty, Balloon; Central Nervous System Stimulants; Humans; Infarction, Mid | 2013 |
Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Cell Differentiation; Cell Line, Transformed; D | 2001 |